HHS-OIG – Page 5 – Policy & Medicine

HHS OIG Issues Advisory Opinion on Continuing Medical Education, Stark Law Violations

HHS OIG Identifies Opportunities to Strengthen NIH Grantees’ Oversight of Investigators’ Foreign Financial Interests

HHS OIG Report Finds that Medicare Could Save Money with Increased Biologic Use

HHS OIG Releases Data Brief on Trends with Rapid Growth of Genetic Testing

HHS OIG Report Finds Many Medicare Beneficiaries Are Not Receiving Medication to Treat Opioid Use Disorder

HHS OIG Updates Health Care Fraud Self-Disclosure Protocol

HHS OIG and DOJ Release Annual Report

Medicare Overpaid New Hospitals for Capital Costs When Compared to IPPS

HHS OIG Report Covers Part D Plans Including Drugs Commonly Used by Dual Eligibles

HHS Pulls 340B Advisory Opinion